Evidence map›Paper›PMID 11278615›Full record

ArticleThe Journal of biological chemistry2001

Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site.

S L Rogalski, C Chavkin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Capsaicin inhibits intestinal ClThe Journal of biological chemistry · 2022
    Article
  4. Article
  5. Eag1 KOxidative medicine and cellular longevity · 2017
    Review
  6. Review
  7. Review
  8. Arachidonic acid and ion channels: an update.British journal of pharmacology · 2008
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Activation of hEAG1 potassium channels by arachidonic acid.Pflugers Archiv : European journal of physiology · 2007
    Article
  14. M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S L RogalskiDepartment of Pharmacology University of Washington, Seattle, Washington 98195-7280, USA.
C Chavkin
University of Washington · US

Funding

Regulation of Opioid Signaling by Tyr-PhosphorylationR37DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2004 to 2013
$2.5M
HIPPOCAMPAL OPIOID RECEPTORS &MORPHINE TOLERANCER01DA004123 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 1988 to 2004
$1.1M
NIDA NIH HHS DA 04123NIDA NIH HHS R01 DA004123NIDA NIH HHS R37 DA011672
6 · The paper itself

Abstract

We previously showed that activation of the human endothelin A receptor (HETAR) by endothelin-1 (Et-1) selectively inhibits the response to mu opioid receptor (MOR) activation of the G-protein-gated inwardly rectifying potassium channel (Kir3). The Et-1 effect resulted from PLA2 production of an eicosanoid that inhibited Kir3. In this study, we show that Kir3 inhibition by eicosanoids is channel subunit-specific, and we identify the site within the channel required for arachidonic acid sensitivity. Activation of the G-protein-coupled MOR by the selective opioid agonist D-Ala(2)Glyol, enkephalin, released Gbetagamma that activated Kir3. The response to MOR activation was significantly inhibited by Et-1 activation of HETAR in homomeric channels composed of either Kir3.2 or Kir3.4. In contrast, homomeric channels of Kir3.1 were substantially less sensitive. Domain deletion and channel chimera studies suggested that the sites within the channel required for Et-1-induced inhibition were within the region responsible for channel gating. Mutation of a single amino acid in the homomeric Kir3.1 to produce Kir3.1(F137S)(N217D) dramatically increased the channel sensitivity to arachidonic acid and Et-1 treatment. Complementary mutation of the equivalent amino acid in Kir3.4 to produce Kir3.4(S143T)(D223N) significantly reduced the sensitivity of the channel to arachidonic acid- and Et-1-induced inhibition. The critical aspartate residue required for eicosanoid sensitivity is the same residue required for Na(+) regulation of PIP(2) gating. The results suggest a model of Kir3 gating that incorporates a series of regulatory steps, including Gbetagamma, PIP(2), Na(+), and arachidonic acid binding to the channel gating domain.

Indexed as

Ion Channel GatingPotassium Channel BlockersAnimalsEicosanoidsGTP-Binding ProteinsHumansMutagenesis, Site-DirectedPhosphatidylinositol 4,5-DiphosphatePotassium ChannelsRatsSodiumEicosanoidsGTP-Binding ProteinsPhosphatidylinositol 4,5-DiphosphatePotassium Channel BlockersPotassium ChannelsSodium

Identifiers

PMID11278615
PMCPMC1262640
OpenAlexW2071879235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.